Medicines for Europe urgent requests to Interior & Transport ministries regarding medicines production and supply

16 March 2020

Medicines for Europe statement on COVID-19 (‘coronavirus’)

13 March 2020

European Industries welcome an important industry focus from the European Commission

11 March 2020

Coordination with industry on potential impact of Covid-19 on medicines manufacturing and supplies in Europe

10 March 2020

Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy

3 March 2020

Equitable and sustainable access to medicines is a concern across […]

Impact of COVID-19 on active ingredient and medicines manufacturing and supplies in Europe

18 February 2020

The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe

7 February 2020

Time to modernise the EU pharmaceutical regulatory framework to deliver on access

30 January 2020

To maintain its leadership in pharmaceutical regulatory science, the EU […]

Smart Pharmacovigilance Essential for Patient Safety

29 January 2020

Medicines are developed and manufactured to help patients so, it […]

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs

16 January 2020